Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glycyrrhizic Acid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 1257 Specimen Handling 843 Carboplatin 816 Cyclophosphamide 801 Magnetic Resonance Spectroscopy 784 Cisplatin 699 Nivolumab 671 Paclitaxel 615 Radiotherapy 567 Gemcitabine 556 Biopsy 514 Bevacizumab 464 Dexamethasone 441 fludarabine 389 venetoclax 376 Docetaxel 374 Oxaliplatin 362 Fluorouracil 359 Capecitabine 350 atezolizumab 341 Rituximab 340 durvalumab 330 Doxorubicin 316 Pemetrexed 306 Radiosurgery 303 Ipilimumab 302 Drug Therapy 294 Standard of Care 292 Lenalidomide 279 Radiation 278

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06378346 2026-02-23

GU-01

University of Illinois at Chicago

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡